MYPET OncoTherapeutics

Development of scalable technology for individualized therapeutic cancer vaccine for pets. US market, unmet need. Time to market: 2 years

  • Stage Concept Only
  • Industry Biotechnology
  • Location Athens, GA, USA
  • Currency USD

Company Summary

Start-up biopharma company. What we do now: 1) provisional patent application: proprietary technology, 2) developing protocols for proof of concept experimental studies, 3) actively looking for partners/investors. Similar widely accessible product is not available currently. Short time to market is based on simplified regulatory pathway for such products in US. Customers: pets' owners. Prominent perspective in regards to development for humans

Team

  • x x
    President & CEO

    PhD (Immunology). Seasoned professional with 20+ year’s proven track record in R&D for biopharmaceuticals including therapeutic cancer vaccines. Director level R&D position at known biopharma company. Business development experience. Multidisciplinary background. Founded successful start-up company and developed business. This company is a market leader now. Extensive international experience (USA, Canada, Europe).

  • x x
    Strategic adviser and Member of the board

    MBA degree. Seasoned professional with 25+ years' experience in marketing and business development for pharmaceuticals. Lead multidisciplinary teams to successful launch of several medicines (time- and cost-effectively). Extensive experience in Europe, USA, Canada with impressive network and excellent professional reputation.

  • Alexander Gaydamaka

Advisors

  • NA
    Lawyer
    Unconfirmed
    NA
    Accountant
    Unconfirmed

Previous Investors

  • NA
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free